Chimeric virus-like particles carrying muc1 tumor antigen epitope pdtrp and its application in pancreatic cancer
A tumor antigen, pancreatic cancer technology, applied in the fields of medicine and bioengineering, can solve the problems of vaccine prevention or treatment of pancreatic cancer that have not been reported in the literature, and achieve the effects of low production cost, easy promotion and simple method
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] Experimental Materials:
[0031] Table 1
[0032]
[0033]
[0034] 1. Chimeric HBc-VLP gene synthesis
[0035] a, related information of gene synthesis: gene name: HBcP gene length: 459bp, cloning vector: pET28a, cloning site: NdeI / XhoI, cloning vector resistance: Kan, structure diagram ( figure 1 ).
[0036] b. The synthesis of DNA fragments by the phosphoramidite triester method has the characteristics of high efficiency, fast coupling and relatively stable starting reactants. This method completes the synthesis of DNA strands on a solid-phase carrier, and the synthesis direction is along the 3' end to the 5' end of the primer to be synthesized, and the adjacent nucleotides are connected by 3'→5' phosphodiester bonds .
[0037] c. Vector construction: Digest the synthetic target gene fragment and the vector with restriction endonucleases XhoI and NdeI respectively
[0039]
[0040]
[0041] d. Connection:
[0042] Co...
Embodiment 2
[0120] PDTRP polypeptide can protect BALB / c mice after pancreatic cancer cell tumor formation
[0121] Pancreatic cancer chimeric HBc-VLP vaccine with MUC1 tumor antigen epitope PDTRP gene and HBc-VLP control without MUC1 tumor antigen epitope PDTRP were immunized in vivo at week 0 and week 4, respectively, and at week 2 after the last immunization. Weeks later, PANC1-PDTRP tumor cells were inoculated subcutaneously, and the tumor formation in mice of different experimental groups was observed.
[0122] Experimental results
[0123] See Figure 7 , it can be seen from the experimental results that compared with the negative control, the injection of the chimeric vaccine carrying MUC1 can inhibit the tumorigenesis of tumor cells.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


